BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32794257)

  • 1. Identification of proteins associated with development of metastasis from cutaneous squamous cell carcinomas (cSCCs) via proteomic analysis of primary cSCCs.
    Shapanis A; Lai C; Smith S; Coltart G; Sommerlad M; Schofield J; Parkinson E; Skipp P; Healy E
    Br J Dermatol; 2021 Apr; 184(4):709-721. PubMed ID: 32794257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating proteome changes between primary and metastatic cutaneous squamous cell carcinoma using SWATH mass spectrometry.
    Azimi A; Lo K; Kim J; Fernandez-Penas P
    J Dermatol Sci; 2020 Aug; 99(2):119-127. PubMed ID: 32651104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas.
    Föll MC; Fahrner M; Gretzmeier C; Thoma K; Biniossek ML; Kiritsi D; Meiss F; Schilling O; Nyström A; Kern JS
    Matrix Biol; 2018 Mar; 66():1-21. PubMed ID: 29158163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
    Levine DE; Karia PS; Schmults CD
    JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA expression as a risk factor for metastases of cutaneous squamous-cell carcinoma in organ- transplant recipients.
    de Jong E; Quint KD; El Ghalbzouri A; Verdijk RM; Goeman JJ; Heidt S; Claas FHJ; de Fijter JW; Genders RE; Vermeer MH; Bouwes Bavinck JN
    Hum Immunol; 2023 Mar; 84(3):208-213. PubMed ID: 36621381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico Analysis Validates Proteomic Findings of Formalin-fixed Paraffin Embedded Cutaneous Squamous Cell Carcinoma Tissue.
    Azimi A; Kaufman KL; Ali M; Kossard S; Fernandez-Penas P
    Cancer Genomics Proteomics; 2016 11-12; 13(6):453-465. PubMed ID: 27807068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
    Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
    J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate and Characteristics of Incompletely Excised Cutaneous Squamous Cell Carcinoma: A Dermatological Daily Practice Multicenter Prospective Cohort Study.
    van Lee CB; Kouloubis N; Wakkee M; Kelleners-Smeets NWJ; Nellen RGL; van Rengen A; de Vijlder HC; Wijne LCC; Nijsten T; van den Bos RR
    Dermatol Surg; 2022 Dec; 48(12):1269-1273. PubMed ID: 36194767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated tissue proteome and metabolome reveal key elements and regulatory pathways in cutaneous squamous cell carcinoma.
    Chen W; Rao J; Liu Z; You X; Yuan F; Le F; Tang M; Zhou M; Xie T
    J Proteomics; 2021 Sep; 247():104320. PubMed ID: 34237460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasis suppressor proteins in cutaneous squamous cell carcinoma.
    Bozdogan O; Vargel I; Cavusoglu T; Karabulut AA; Karahan G; Sayar N; Atasoy P; Yulug IG
    Pathol Res Pract; 2016 Jul; 212(7):608-15. PubMed ID: 27215390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive profiling identifies tumour and immune microenvironmental differences in clinical subsets of cutaneous squamous cell carcinoma.
    Thai AA; Young RJ; Bressel M; Angel C; McDowell L; Tiong A; Bucknell NW; Fellowes A; Xu H; Trigos A; Rischin D; Solomon BJ
    Br J Dermatol; 2023 Oct; 189(5):588-602. PubMed ID: 37470440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.
    Yilmaz AS; Ozer HG; Gillespie JL; Allain DC; Bernhardt MN; Furlan KC; Castro LT; Peters SB; Nagarajan P; Kang SY; Iwenofu OH; Olencki T; Teknos TN; Toland AE
    Cancer; 2017 Apr; 123(7):1184-1193. PubMed ID: 27906449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulative incidence and timing of subsequent cutaneous squamous cell carcinomas stratified for patients with organ transplantation and hematologic malignancies: A nationwide cohort study.
    Eggermont CJ; Hollestein LM; Hollatz A; Louwman M; Mooyaart AL; Nijsten T; Wakkee M
    J Am Acad Dermatol; 2024 Mar; 90(3):530-536. PubMed ID: 37871807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of genetic mutations of cutaneous squamous cell carcinoma using whole exome sequencing in non-Caucasian population.
    Lee SY; Lee M; Yu DS; Lee YB
    J Dermatol Sci; 2022 May; 106(2):70-77. PubMed ID: 35365379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model.
    Rentroia-Pacheco B; Tokez S; Bramer EM; Venables ZC; van de Werken HJG; Bellomo D; van Klaveren D; Mooyaart AL; Hollestein LM; Wakkee M
    EClinicalMedicine; 2023 Sep; 63():102150. PubMed ID: 37662519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
    Que SKT; Zwald FO; Schmults CD
    J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poorly differentiated cutaneous squamous cell carcinomas have high incomplete excision rates with UK minimum recommended pre-determined surgical margins.
    Kiely J; Kostusiak M; Bloom O; Roshan A
    J Plast Reconstr Aesthet Surg; 2020 Jan; 73(1):43-52. PubMed ID: 31473117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Fargnoli MC; Forsea AM; Frenard C; Harwood CΑ; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
    Eur J Cancer; 2020 Mar; 128():60-82. PubMed ID: 32113941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
    Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of PSCA, PIWIL1 and TBX2 and its correlation with HPV16 infection in formalin-fixed, paraffin-embedded cervical squamous cell carcinoma specimens.
    Liu WK; Jiang XY; Zhang ZX
    Arch Virol; 2010 May; 155(5):657-63. PubMed ID: 20229117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.